$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 19.64% on an annualized basis, producing an average annual return of 28.49%. If an investor had bought $100 of REGN stock 15 years ago, it would be worth $4,613.39 today.
July 11, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals has shown strong performance over the past 15 years, outperforming the market by 19.64% on an annualized basis.
The article highlights the strong performance of Regeneron Pharmaceuticals over the past 15 years. This historical performance could attract investors looking for long-term investments, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100